The text as introduced · 499 words
89R12070 CJD-D
By: Hall
S.B. No. 1986
A BILL TO BE ENTITLED
AN ACT
relating to warning labels for opioid prescription drugs.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 481.074(a), Health and Safety Code, is
amended to read as follows:
(a) A pharmacist may not:
(1) dispense or deliver a controlled substance or
cause a controlled substance to be dispensed or delivered under the
pharmacist's direction or supervision except under a valid
prescription and in the course of professional practice;
(2) dispense a controlled substance if the pharmacist
knows or should have known that the prescription was issued without
a valid patient-practitioner relationship;
(3) fill a prescription that is not prepared or issued
as prescribed by this chapter;
(4) permit or allow a person who is not a licensed
pharmacist or pharmacist intern to dispense, distribute, or in any
other manner deliver a controlled substance even if under the
supervision of a pharmacist, except that after the pharmacist or
pharmacist intern has fulfilled his professional and legal
responsibilities, a nonpharmacist may complete the actual cash or
credit transaction and delivery; [ or ]
(5) permit the delivery of a controlled substance to
any person not known to the pharmacist, the pharmacist intern, or
the person authorized by the pharmacist to deliver the controlled
substance without first requiring identification of the person
taking possession of the controlled substance, except as provided
by Subsection (n) ; or
(6) dispense an opioid unless the bottle or container
in which the opioid is dispensed is affixed with a label warning of
the addictive nature of opioids and the risks of respiratory
depression and overdose as required by board rule under Section
481.0761(l) .
SECTION 2. Section 481.0761, Health and Safety Code, is
amended by adding Subsection (l) to read as follows:
(l) The board shall adopt rules requiring that an opioid be
dispensed in a bottle or container affixed with a label warning
users of the addictive nature of opioids and the risks of
respiratory depression and overdose. The label must include
language substantially similar to the following:
"CAUTION: Opioid. Risk of Addiction, Respiratory Depression,
and Overdose.".
SECTION 3. The Texas State Board of Pharmacy shall adopt the
rules required under Section 481.0761(l), Health and Safety Code,
as added by this Act, not later than January 1, 2026.
SECTION 4. The change in law made by this Act applies only
to a prescription for an opioid dispensed on or after March 1, 2026.
A prescription dispensed before March 1, 2026, is governed by the
law in effect immediately before the effective date of this Act, and
the former law is continued in effect for that purpose.
SECTION 5. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2025.
Monitoring 
